Sun Moon Pharmaceuticals Private Limited, a active private limited company, was established on 20 April 2000 in Boisar, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2000PTC126022. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 21 professional, Its leadership includes Amarnath Harischandra Upadhyay (Director), Santoshkumar Amarnath Upadhyay (Director). It holds ₹10.18 Cr open charges and ₹8.80 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. N-65, Midc Tarapur Boisar Palghar, Boisar, Maharashtra, 401505.
U24230MH2000PTC126022
126022
20 April 2000
₹0.50 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Sun Moon Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amarnath Harischandra Upadhyay | Director | 20 Apr 2000 | Current |
| Santoshkumar Amarnath Upadhyay | Director | 19 Nov 2005 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sun Moon Pharmaceuticals Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.2% decrease. The company also saw a substantial improvement in profitability, with a 239.38% increase in profit. The company's net worth moved up by a moderate rise of 4.23%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sun Moon Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹101,800,000.00
₹8,800,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2023 | Others | ₹6.18 Cr | Open |
| 01 May 2022 | Others | ₹4.00 Cr | Open |
| 20 Sep 2021 | Others | ₹2.50 M | Satisfied |
| 20 Sep 2021 | Others | ₹0.80 M | Satisfied |
| 08 May 2018 | Others | ₹1.50 M | Satisfied |
Explore comprehensive loan charge details -
Sun Moon Pharmaceuticals has a workforce of 21 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sun Moon Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sun Moon Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sun Moon Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Sun Moon Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 61.80 M with Charge ID 100830908 was registered on 10 Nov 2023. was completed.
The activity A charge registered on 20 Sep 2021 via Charge ID 100487778 with Others was fully satisfied on 05 May 2022. was completed.
Progress on A charge registered on 20 Sep 2021 via Charge ID 100487774 with Others was fully satisfied on 05 May 2022. was documented.
Progress on A charge registered on 08 May 2018 via Charge ID 100183127 with Others was fully satisfied on 05 May 2022. was documented.
The CIN of Sun Moon Pharmaceuticals Private Limited is U24230MH2000PTC126022.
Sun Moon Pharmaceuticals Private Limited is headquartered at Plot No. N-65, Midc Tarapur Boisar Palghar, Boisar, Maharashtra, 401505.
Sun Moon Pharmaceuticals Private Limited was incorporated on 20 April 2000.
The current directors of Sun Moon Pharmaceuticals Private Limited are
The primary industry of Sun Moon Pharmaceuticals Private Limited is Manufacturing.
Sun Moon Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sun Moon Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sun Moon Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX